Talal AH, Lafleur J, Hoop RS, Pandya P, Martin P, Jacobson IM, Han J, Korner EJ. Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C--authors' reply.
Aliment Pharmacol Ther 2013;
38:554-5. [PMID:
23937463 DOI:
10.1111/apt.12424]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2013] [Accepted: 07/01/2013] [Indexed: 12/08/2022]